Jafron Biomedical (China) Performance
| 300529 Stock | 30.64 0.68 2.27% |
On a scale of 0 to 100, Jafron Biomedical holds a performance score of 7. The company retains a Market Volatility (i.e., Beta) of -0.57, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Jafron Biomedical are expected to decrease at a much lower rate. During the bear market, Jafron Biomedical is likely to outperform the market. Please check Jafron Biomedical's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Jafron Biomedical's current trending patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Jafron Biomedical Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jafron Biomedical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0134 | Payout Ratio 0.4183 | Last Split Factor 1.9:1 | Forward Dividend Rate 0.4 | Ex Dividend Date 2024-05-31 |
1 | Jafron BiomedicalLtd Seems To Use Debt Rather Sparingly - Simply Wall St | 11/22/2024 |
| Begin Period Cash Flow | 2.5 B |
Jafron |
Jafron Biomedical Relative Risk vs. Return Landscape
If you would invest 2,509 in Jafron Biomedical Co on August 29, 2024 and sell it today you would earn a total of 487.00 from holding Jafron Biomedical Co or generate 19.41% return on investment over 90 days. Jafron Biomedical Co is generating 0.3841% of daily returns and assumes 4.0588% volatility on return distribution over the 90 days horizon. Simply put, 36% of stocks are less volatile than Jafron, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jafron Biomedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jafron Biomedical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jafron Biomedical Co, and traders can use it to determine the average amount a Jafron Biomedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0946
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300529 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.06 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Jafron Biomedical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jafron Biomedical by adding it to a well-diversified portfolio.
Jafron Biomedical Fundamentals Growth
Jafron Stock prices reflect investors' perceptions of the future prospects and financial health of Jafron Biomedical, and Jafron Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jafron Stock performance.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.31 % | ||||
| Operating Margin | 0.42 % | ||||
| Current Valuation | 22.83 B | ||||
| Shares Outstanding | 798.6 M | ||||
| Price To Book | 7.27 X | ||||
| Price To Sales | 9.17 X | ||||
| Revenue | 1.92 B | ||||
| Gross Profit | 2.27 B | ||||
| EBITDA | 1.04 B | ||||
| Net Income | 436.49 M | ||||
| Total Debt | 261.83 M | ||||
| Book Value Per Share | 4.25 X | ||||
| Cash Flow From Operations | 916.74 M | ||||
| Earnings Per Share | 1.00 X | ||||
| Total Asset | 5.54 B | ||||
| Retained Earnings | 2 B | ||||
About Jafron Biomedical Performance
By analyzing Jafron Biomedical's fundamental ratios, stakeholders can gain valuable insights into Jafron Biomedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Jafron Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jafron Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Jafron Biomedical is entity of China. It is traded as Stock on SHE exchange.Things to note about Jafron Biomedical performance evaluation
Checking the ongoing alerts about Jafron Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jafron Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jafron Biomedical had very high historical volatility over the last 90 days | |
| Jafron Biomedical is unlikely to experience financial distress in the next 2 years | |
| About 51.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Jafron BiomedicalLtd Seems To Use Debt Rather Sparingly - Simply Wall St |
- Analyzing Jafron Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jafron Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Jafron Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jafron Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jafron Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jafron Biomedical's stock. These opinions can provide insight into Jafron Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Jafron Stock analysis
When running Jafron Biomedical's price analysis, check to measure Jafron Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jafron Biomedical is operating at the current time. Most of Jafron Biomedical's value examination focuses on studying past and present price action to predict the probability of Jafron Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jafron Biomedical's price. Additionally, you may evaluate how the addition of Jafron Biomedical to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |